Pharma Focus Asia

Thermo Fisher Scientific Invests US$58 million to Expand Research Laboratory in Wisconsin, USA


Thermo Fisher Scientific is investing $58 million to expand its GMP lab in Wisconsin, USA.


This new state-of-the-art facility spans 72,500 square feet and includes a clinical research laboratory building. This expansion will enhance the site's chemistry, manufacturing, and control (CMC) analytical capabilities, supporting the mission to improve global health by aiding the delivery of life-changing medicines.

The investment underscores the commitment to create a healthier, cleaner, and safer world. With the expansion, the site will now deliver comprehensive end-to-end laboratory services, offering high-quality analytical support for both small molecules and biologics. 

This includes biopharmaceuticals, inhaled pharmaceuticals and device testing, cell and gene therapy, protein characterisation, and mass spectrometry analysis across all drug development phases.

The new addition to the GMP campus features a versatile biosafety level 2 laboratory with a specialised liquid chromatography-mass spectrometry and protein characterisation space, two large molecular suites with access-controlled pre- and post-amplification labs, and two spacious general-use labs. 

This expansion will create up to 350 new positions for scientists and laboratory support professionals, adding to the nearly 2,300 employees already at the research campus.


Name       Thermo Fisher Scientific
Type          Expansion
Budget    US$58 million

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference